title: Neuroleptic dose reduction in persistently psychotic patients.
authors.affiliation: Psychiatry Service, VA Medical Center, Brockton, Massachusetts 02401.
authors.forename: S V
authors.initials: SV
authors.lastname: Faraone
authors.forename: A I
authors.initials: AI
authors.lastname: Green
authors.forename: W
authors.initials: W
authors.lastname: Brown
authors.forename: P
authors.initials: P
authors.lastname: Yin
authors.forename: M T
authors.initials: MT
authors.lastname: Tsuang
mesh_terms: D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000517:prevention & control; D005476:Fluphenazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents; C011825:fluphenazine depot; D005476:Fluphenazine